{"id":"placebo-sd-101-0-0-cream","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108947","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"SD-101-0.0 is an inert topical formulation used as a control comparator in clinical trials. It relies on patient expectation and the natural healing process rather than any pharmacological action. Placebo formulations are essential for establishing the true efficacy of investigational drugs by distinguishing genuine drug effects from psychological and natural disease resolution.","oneSentence":"Placebo cream contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:28:27.593Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control comparator in phase 3 clinical trials (specific indication unknown)"}]},"trialDetails":[{"nctId":"NCT02384460","phase":"PHASE3","title":"ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa","status":"COMPLETED","sponsor":"Scioderm, Inc.","startDate":"2015-03-11","conditions":"Epidermolysis Bullosa","enrollment":169},{"nctId":"NCT02014376","phase":"PHASE2","title":"Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa","status":"COMPLETED","sponsor":"Scioderm, Inc.","startDate":"2014-01-06","conditions":"Epidermolysis Bullosa","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1743,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["placebo"],"phase":"phase_3","status":"active","brandName":"Placebo (SD-101-0.0) cream","genericName":"Placebo (SD-101-0.0) cream","companyName":"Scioderm, Inc.","companyId":"scioderm-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo cream contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect. Used for Control comparator in phase 3 clinical trials (specific indication unknown).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}